| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Immunology and Microbiology, Rush University Medical Center, Chicago, IL 60612;
Group of Immunovirology, Biogenesis Corporation, University of Antioquia, Medellin, Colombia, South America;
Coley Pharmaceutical Group, Wellesley, MA 02481; and
Diabetes Unit, Massachusetts General Hospital, Boston, MA 02139
CD1d-restricted invariant NK T (iNKT) cells and dendritic cells (DCs) have been shown to play crucial roles in various types of immune responses, including TLR9-dependent antiviral responses initiated by plasmacytoid DCs (pDCs). However, the mechanism by which this occurs is enigmatic because TLRs are absent in iNKT cells and human pDCs do not express CD1d. To explore this process, pDCs were activated with CpG oligodeoxyribonucleotides, which stimulated the secretion of several cytokines such as type I and TNF-
. These cytokines and other soluble factors potently induced the expression of activation markers on iNKT cells, selectively enhanced double-negative iNKT cell survival, but did not induce their expansion or production of cytokines. Notably, pDC-derived factors licensed iNKT cells to respond to myeloid DCs: an important downstream cellular target of iNKT cell effector function and a critical contributor to the initiation of adaptive immune responses. This interaction supports the notion that iNKT cells can mediate cross-talk between DC subsets known to express mutually exclusive TLR and cytokine profiles.
This article has been cited by other articles:
|
|
 |
|
  K. Azakami, T. Sato, N. Araya, A. Utsunomiya, R. Kubota, K. Suzuki, D. Hasegawa, T. Izumi, H. Fujita, S. Aratani, et al. Severe loss of invariant NKT cells exhibiting anti-HTLV-1 activity in patients with HTLV-1-associated disorders Blood, October 8, 2009; 114(15): 3208 - 3215. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Paget, E. Bialecki, J. Fontaine, C. Vendeville, T. Mallevaey, C. Faveeuw, and F. Trottein Role of Invariant NK T Lymphocytes in Immune Responses to CpG Oligodeoxynucleotides J. Immunol., February 15, 2009; 182(4): 1846 - 1853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. W. Stout-Delgado, X. Yang, W. E. Walker, B. M. Tesar, and D. R. Goldstein Aging Impairs IFN Regulatory Factor 7 Up-Regulation in Plasmacytoid Dendritic Cells during TLR9 Activation J. Immunol., November 15, 2008; 181(10): 6747 - 6756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Tyznik, E. Tupin, N. A. Nagarajan, M. J. Her, C. A. Benedict, and M. Kronenberg Cutting Edge: The Mechanism of Invariant NKT Cell Responses to Viral Danger Signals J. Immunol., October 1, 2008; 181(7): 4452 - 4456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Fujiwara, B. Wei, L. L. Presley, S. Brewer, M. McPherson, M. A. Lewinski, J. Borneman, and J. Braun Systemic Control of Plasmacytoid Dendritic Cells by CD8+ T Cells and Commensal Microbiota J. Immunol., May 1, 2008; 180(9): 5843 - 5852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Torres, C. Paget, J. Fontaine, T. Mallevaey, T. Matsuoka, T. Maruyama, S. Narumiya, M. Capron, P. Gosset, C. Faveeuw, et al. Prostaglandin D2 Inhibits the Production of IFN-{gamma} by Invariant NK T Cells: Consequences in the Control of B16 Melanoma J. Immunol., January 15, 2008; 180(2): 783 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Salio, A. O. Speak, D. Shepherd, P. Polzella, P. A. Illarionov, N. Veerapen, G. S. Besra, F. M. Platt, and V. Cerundolo Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation PNAS, December 18, 2007; 104(51): 20490 - 20495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. John and P. J. Nelson Dendritic Cells in the Kidney J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2628 - 2635. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
